Relations of plasma homocysteine to left ventricular structure and function: The Framingham Heart Study

European Heart Journal

Volumn 25, Issue 6, 2004, Pages 523-530

  Sundström, Johan ^a   Sullivan, Lisa ^c   Selhub, Jacob ^d   Benjamin, Emelia J ^a,b   D'Agostino, Ralph B ^c   Jacques, Paul F ^d   Rosenberg, Irwin H ^d   Levy, Daniel ^a,b,e   Wilson, Peter W F ^a   Vasan, Ramachandran S ^a,b  

^a FRAMINGHAM HEART STUDY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Boston University   (United States)

^d TUFTS UNIVERSITY   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Echocardiography; Heart failure; Left Ventricular hypertrophy; Left ventricular remodelling; Metabolism

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR PARAMETERS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HEART SIZE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MUSCLE REGENERATION; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; TISSUE STRUCTURE;

CARDIAC VOLUME; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SEX CHARACTERISTICS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 11144356292     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.01.008     Document Type: Article

References (33)

1. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002;288(16):2015-22.
2. Vasan RS, Beiser A, D'Agostino RB et al. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. JAMA 2003;289(10):1251.
3. Joseph J, Washington A, Joseph L et al. Hyperhomocysteinemia leads to adverse cardiac remodeling in hypertensive rats. Am J Physiol Heart Circ Physiol 2002;283(6):H2567-74.
4. Miller A, Mujumdar V, Palmer L et al. Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats. Am J Hypertens 2002;5(2 Pt 1):157-63.
5. Jacques PF, Bostom AG, Wilson PW et al. Determinants of plasma total homocysteine concentration in the Framingham Offspring Cohort. Am J Clin Nutr 2001;73(3):613-21.
6. Lim U, Cassano PA. Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 2002;156(12):1105-13,
7. Nygard O, Vollset SE, Refsum H et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995;274(19):1526-33.
8. Blacher J, Demuth K, Guerin AP et al. Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease. J Nephrol 1999;12(4):248-55.
9. Wocial B, Berent H, Kostrubiec M et al. Homocysteine, adrenergic activity and left ventricular mass in patients with essential hypertension. Blood Press 2002;11(4):201-5.
10. Kannel WB, Feinleib M, McNamara PM et al. An investigation of coronary heart disease in families. The Framingham Offspring Study. Am J Epidemiol 1979;110:281-90.
11. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43-52.
12. Selhub J, Jacques PF, Wilson PWF et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-8.
13. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch. Intern. Med. 1997;157(21):2413-46.
14. American Diabetes Association: clinical practice recommendations 1997. Diabetes Care 1997;20(Suppl 1):S1-70.
15. Kannel WB, Wolf PA, Garrison RJ. The Framingham Study: an epidemiological investigation of cardiovascular disease. Section 34: some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements. Framingham Heart Study, 30-Year Follow-Up, NIH Publication No. 87-2703, Bethesda, 1987, p. 1-462.
16. Sahn DJ, DeMaria A, Kisslo J et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58(6): 1072-83.
17. Devereux RB, Alonso DR, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57(6):450-8.
18. Wang TJ, Evans JC, Benjamin EJ et al. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 2003;108(8):977-82.
19. Majors A, Ehrhart LA, Pezacka EH. Homocysteine as a risk factor for vascular disease: enhanced collagen production and accumulation by smooth muscle cells. Arterioscler Thromb Vasc Biol 1997; 17(10):2074-81.
20. Tsai JC, Perrella MA, Yoshizumi M et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 1994;91(14):6369-73.
21. Tyagi SC. Homocysteine redox receptor and regulation of extracellular matrix components in vascular cells. Am J Physiol 1998;274(2 Pt 1):C396-405.
22. Mujumdar VS, Aru GM, Tyagi SC. Induction of oxidative stress by homocyst(e)ine impairs endothelial function. J Cell Biochem 2001; 82(3):491-500.
23. Chambers JC, McGregor A, Jean-Marie J et al. Acute hyperhomocysteinaemia and endothelial dysfunction. Lancet 1998; 351(9095):36-7.
24. Lentz SR, Sobey CG, Piegors DJ et al. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest 1996; 98(1):24-9.
25. Verhoef P. Hyperhomocysteinemia and risk of vascular disease in women. Semin Thromb Hemost 2000;26(3):325-34.
26. Selhub J, Jacques PF, Bostom AG et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995;332(5):286.
27. Krumholz HM, Larson M, Levy D. Sex differences in cardiac adaptation to isolated systolic hypertension. Am J Cardiol 1993;72:310-3.
28. Weinberg EO, Thienelt CD, Katz SE et al. Gender differences in molecular remodeling in pressure overload hypertrophy. J Am Coll Cardiol 1999;34(1):264-73.
29. +-ATPase activity by the metabolites accumulating in homocystinuria. Metab Brain Dis 2002;17(2):83-91.
30. Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 2002;347(18):1403-11.
31. Hayward CS, Webb CM, Collins P. Effect of sex hormones on cardiac mass. Lancet 2001;357(9265):1354-6.
32. Dimitrova KR, DeGroot K, Myers AK et al. Estrogen and homocysteine. Cardiovasc Res 2002;53(3):577-88.
33. Jacques PF, Sethub J, Bostom AG et at. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340(19):1449-54.